Nang Kuang Pharmaceutical Co., Ltd.

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 2 137
EBIT TTM (mln): 132
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Rok finansowy 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 670 653 813 952 1,013 1,277 1,520 1,550 1,504 1,539 1,762 1,755 1,780 1,940 2,150 2,200
Przychód Δ r/r 0.0% -2.6% 24.6% 17.1% 6.4% 26.0% 19.1% 1.9% -3.0% 2.3% 14.5% -0.4% 1.4% 9.0% 10.8% 2.3%
Marża brutto 35.4% 31.2% 30.9% 34.5% 29.3% 32.1% 36.1% 37.1% 34.3% 32.5% 35.3% 34.0% 33.4% 35.8% 35.1% 34.0%
EBIT (mln) 19 -8 32 103 16 91 236 276 222 123 256 230 234 418 260 308
EBIT Δ r/r 0.0% -142.0% -497.8% 219.0% -84.7% 476.9% 159.4% 16.9% -19.7% -44.5% 108.1% -10.0% 1.4% 78.7% -37.8% 18.3%
EBIT (%) 2.9% -1.2% 4.0% 10.8% 1.6% 7.1% 15.5% 17.8% 14.7% 8.0% 14.5% 13.1% 13.1% 21.5% 12.1% 14.0%
Koszty finansowe (mln) 5 11 14 15 10 8 10 6 4 4 3 4 4 5 7 6
EBITDA (mln) 89 77 132 210 137 244 400 448 400 319 449 416 414 594 482 492
EBITDA(%) 13.2% 11.8% 16.2% 22.0% 13.5% 19.1% 26.3% 28.9% 26.6% 20.8% 25.5% 23.7% 23.2% 30.6% 22.4% 22.4%
Podatek (mln) 6 -9 5 13 14 15 28 45 32 17 33 40 39 59 15 60
Zysk Netto (mln) 12 -11 6 80 -8 67 199 225 186 101 217 183 196 352 198 243
Zysk netto Δ r/r 0.0% -188.7% -158.2% 1204.3% -109.7% -960.6% 195.8% 13.3% -17.6% -45.5% 114.8% -15.7% 6.9% 79.5% -43.6% 22.7%
Zysk netto (%) 1.8% -1.6% 0.8% 8.4% -0.8% 5.3% 13.1% 14.6% 12.4% 6.6% 12.3% 10.5% 11.0% 18.1% 9.2% 11.1%
EPS 0.2 -0.17 0.1 1.22 -0.0914 0.76 2.17 2.25 1.84 1.0 2.17 1.82 1.94 3.49 1.96 2.43
EPS (rozwodnione) 0.2 -0.17 0.1 1.13 -0.0914 0.68 1.98 2.23 1.84 1.0 2.17 1.81 1.94 3.48 1.96 2.43
Ilośc akcji (mln) 59 63 63 66 85 89 92 100 101 101 100 101 101 101 101 101
Ważona ilośc akcji (mln) 59 63 63 75 85 101 101 101 101 101 100 101 101 101 101 101
Waluta TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD